Keratinocyte cancer incidence in Australia: a review of population-based incidence trends and estimates of lifetime risk
Abstract
Objectives: To review the most recent population-based estimates of keratinocyte cancer incidence in Australia, to describe the trends over time and to calculate lifetime risk of developing these skin cancers. Methods: We conducted a literature search of PubMed/MEDLINE from 2001 to August 2021 to identify relevant literature. We defined eligible articles as those reporting population-based studies of adults and excluded studies that reported only on high-risk or paediatric populations, or on incidence of precursor or related lesions. We summarised identified studies qualitatively. We calculated lifetime risk of developing keratinocyte cancer using the methods of Cancer Research UK, adjusting for multiple primaries and the competing risk of death. Results: We identified six eligible studies. In the absence of compulsory notifications of keratinocyte cancer to state and territory cancer registries in Australia, all estimates of national incidence rates of basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) have limitations. The most recent population-based estimates of people annually affected for the period 2011–2014 (BCC: 770/100 000 person years; SCC: 271/100 000 person years) represent the lower end of the possible range of incidence rates nationally. Because many people are affected by multiple lesions, the lesion-based incidence estimates are more than double the person-based rates (BCC: 1565/100 000 person years; SCC: 580/100 000 person years). Analyses of temporal trends in treatment rates (excisions, cryotherapy/curettage) show increases over time, most marked for people aged 55 years or older. We estimate that 69% of Australians will have at least one excision for histologically confirmed keratinocyte cancer in their lifetime (60% to age 79 years). Conclusion: The available evidence on national incidence rates is out of date and of moderate quality, but indicates very high rates of keratinocyte cancer in Australia. We recommend that population-based cancer registries work towards statutory notification and routine reporting of keratinocyte cancer in Australia.Citation
Olsen C, Pandeya N, Green A, Ragaini B, Venn A, Whiteman D. Keratinocyte cancer incidence in Australia: a review of population-based incidence trends and estimates of lifetime risk. Vol. 32, Public Health Research & Practice. The Sax Institute; 2022.Journal
Public Health Res PractDOI
10.17061/phrp3212203PubMed ID
35290995Additional Links
https://dx.doi.org/10.17061/phrp3212203Type
ArticleLanguage
enae974a485f413a2113503eed53cd6c53
10.17061/phrp3212203
Scopus Count
Collections
Related articles
- The incidence and multiplicity rates of keratinocyte cancers in Australia.
- Authors: Pandeya N, Olsen CM, Whiteman DC
- Issue date: 2017 Oct 16
- Exclusive development of a single type of keratinocyte skin cancer: evidence from an Australian population-based cohort study.
- Authors: Keim U, van der Pols JC, Williams GM, Green AC
- Issue date: 2015 Mar
- Forearm hair density and risk of keratinocyte cancers in Australian adults.
- Authors: von Schuckmann LA, Hughes MC, Green AC, van der Pols JC
- Issue date: 2016 Nov
- Incidence Estimate of Nonmelanoma Skin Cancer (Keratinocyte Carcinomas) in the U.S. Population, 2012.
- Authors: Rogers HW, Weinstock MA, Feldman SR, Coldiron BM
- Issue date: 2015 Oct
- Declining incidence of keratinocyte carcinoma in organ transplant recipients.
- Authors: Menzies S, O'Leary E, Callaghan G, Galligan M, Deady S, Gadallah B, Lenane P, Lally A, Houlihan DD, Morris PG, Sexton DJ, McCormick PA, Egan JJ, O'Neill JP, Conlon PJ, Moloney FJ
- Issue date: 2019 Nov